SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Receptagen Ltd. -- Ignore unavailable to you. Want to Upgrade?


To: Paul Thomas who wrote (94)5/6/1998 9:11:00 PM
From: Andre Koluksuz  Read Replies (1) | Respond to of 203
 
I had totally written off my investment in this company. But after reading their latest news release saying that they got another 800K from iNterunion, I am somewhat hopeful again. Any financing deal will probably be not more then 5 cents/share, which will not help us in the short term. But if this turns the company around, and if they can manage to put their product ihn the market , there is a huge potential. But we are looking at couple of years I would say before this happens. But even then, if the stock goes to say 50 cents in 2 years, not a bad return from where it is now.